> Spiro‐oxo‐indole/pyrrolidine‐thiophene base possessed significant pharmacological activity. The [3'/> Regioselective Reactions, Spectroscopic Characterization, and Cytotoxic Evaluation of Spiro‐pyrrolidine Thiophene
首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >Regioselective Reactions, Spectroscopic Characterization, and Cytotoxic Evaluation of Spiro‐pyrrolidine Thiophene
【24h】

Regioselective Reactions, Spectroscopic Characterization, and Cytotoxic Evaluation of Spiro‐pyrrolidine Thiophene

机译:螺吡咯烷噻吩的区域选择性反应,光谱性表征和细胞毒性评价

获取原文
获取原文并翻译 | 示例
           

摘要

> Spiro‐oxo‐indole/pyrrolidine‐thiophene base possessed significant pharmacological activity. The [3?+?2] cycloaddition reactions of thia‐methine ylide respected through multi‐component reaction affording regioselective and stereoselective spiroindoline‐3,2′‐tetrahydrothiophene derivative 3 . Reaction of such compound with different electrophilic and nucleophilic reagents afforded bioactive heterocyclic compounds 4 – 16 . Biological evaluation showed that these synthesized spiro‐pyrrolidine exhibited moderate to good cytotoxic activity. Among them, compounds 7 and 14 displayed the best cytotoxic activity against MCF‐7 and Wl‐38 cells with the IC 50 values of 7.02?±?0.6 and 8.97?±?0.9?μm (very strong), respectively. Compounds 4 , 5 , and 12 exhibited strong cytotoxicity's with IC 50 16.28?±?1.7, 11.16?±?1.1, and 19.14?±?1.7?μm, respectively, against MCF‐7 mammary gland cell line. All compound structures were supported by spectroscopic data and elemental analysis.
机译: >螺氧吲哚/吡咯烷 - 噻吩基底具有显着的药理学活性。 [3?+α2]紫杉醇ylide的环加成反应通过多组分反应尊重,其提供了聚合物反应,其提供全区域和立体选择性螺吲哚-3,2'-四氢噻吩衍生物 3 / b>。这些化合物与不同的亲电和亲核试剂的反应得到了生物活性杂环化合物 4 / B> - 16。生物学评价表明,这些合成的螺吡咯烷表现出中度至良好的细胞毒性活性。其中,化合物 7 和 14 用IC 50 值为7.02的IC 50 值显示最佳的细胞毒性活性? ±0.6和8.97?±0.9?μm(非常强)。化合物 4 , 5 ,和 12 用IC 50 16.28?±1.7,11.16?± ?1.1,19.14?±1.7?μm,针对MCF-7乳腺细胞系。通过光谱数据和元素分析支持所有复合结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号